Q2 2022 Holdings
Filed 2022-08-15 | 80 holdings | $147.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $38.0M | 3,170,872 | 25.8% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $35.1M | 3,000,000 | 23.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.7M | 400,000 | 10.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $13.3M | 1,469,179 | 9.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $11.0M | 1,547,181 | 7.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.9M | 205,000 | 5.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.8M | 750,000 | 4.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $5.8M | 712,079 | 3.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $5.4M | 200,000 | 3.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $4.6M | 50,000 | 3.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.2M | 1,154,424 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.1M | 392,167 | 0.8% |
| Turning Point Therapeutics I | COM | 90041T108 | $186.9K | 2,484,220 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $77.0K | 5,500,000 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $58.5K | 10,505,554 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $57.3K | 2,029,158 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $43.0K | 950,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $38.9K | 1,995,066 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $35.3K | 1,425,000 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $33.4K | 450,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $30.9K | 6,065,001 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $30.6K | 3,850,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $29.2K | 2,012,115 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $28.9K | 2,993,717 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $27.6K | 1,525,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $27.4K | 1,875,000 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $27.1K | 1,730,691 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $26.9K | 184,894 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $26.3K | 1,800,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $25.3K | 1,145,953 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $21.9K | 3,172,204 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $21.3K | 267,500 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $20.4K | 4,507,843 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $20.1K | 300,000 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $18.3K | 322,240 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $15.8K | 125,000 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.7K | 275,000 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $15.3K | 2,840,389 | 0.0% |
| Greenlight Biosciencs Hlds P | COMMON STOCK | 39536G105 | $15.2K | 6,960,540 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $14.4K | 1,087,807 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $14.3K | 2,927,273 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $12.9K | 2,326,660 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $12.4K | 2,286,181 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $12.0K | 868,550 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $11.7K | 475,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $10.7K | 700,710 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.2K | 877,500 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $9.9K | 1,200,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $9.5K | 780,643 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $8.5K | 2,082,000 | 0.0% |